Multiple eruptive dermatofibromas in a patient receiving efalizumab

MeSH terms

• Adult
• Antibodies, Monoclonal / adverse effects*
• Antibodies, Monoclonal / therapeutic use
• Antibodies, Monoclonal, Humanized
• Dermatologic Agents / adverse effects*
• Dermatologic Agents / therapeutic use
• Female
• Histiocytoma, Benign Fibrous / chemically induced*
• Histiocytoma, Benign Fibrous / pathology
• Humans
• Psoriasis / drug therapy*
• Psoriasis / pathology
• Skin Neoplasms / pathology*